drugset / Trial / NCT06736704
SNV4818 in Participants With Advanced Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is testing a new medicine, SNV4818, for people with advanced cancers. The researchers want to find out if SNV4818 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the safest and most effective one.
Timeline
- Start
- 2025-02-20
- Primary completion
- 2027-04
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SNV4818 | Unknown | — | Oral |
| Background | Fulvestrant | Small molecule | 500 mg | Intramuscular |
| Background | Palbociclib | Small molecule | 125 mg | Oral |